Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Carcinoma, Renal Cell

Prostatic Neoplasms

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Hematologic Neoplasms

Brain Neoplasms

Urinary Bladder Neoplasms

Prostatic Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Kidney Neoplasms

Prostate Cancer Metastatic Disease

Lung Neoplasms

Pancreatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Colorectal Neoplasms

Pancreatic Neoplasms

Stomach Neoplasms

Clinical Trials

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

PROSTERA

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating

NeoSRS

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

ARPEGGIO

VVSHIP

SBRT Versus Surgical Resection for Small HCC

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

SACTION 2501

SBRTRC

HIMARS

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

RAD-NALIRIFOX

TOPPGUN-RS

MRI-guided Locoregional SBRT Prostate Program

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)

Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression